Evidence map›Paper›PMID 30867286›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Injured liver-released miRNA-122 elicits acute pulmonary inflammation via activating alveolar macrophage TLR7 signaling pathway.

Yanbo Wang, Hongwei Liang, Fangfang Jin, Xin Yan, Guifang Xu, Huanhuan Hu, Gaoli Liang, Shoubin Zhan, Xiuting Hu, Quan Zhao and 5 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. miR-574-5p in epigenetic regulation and Toll-like receptor signaling.Cell communication and signaling : CCS · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. RNAkines are secreted messengers shaping health and disease.Trends in endocrinology and metabolism: TEM · 2024
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Yanbo WangState Key Laboratory of Pharmaceutical Biotechnology, Department of Gastroenterology, Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 210093 Nanjing, China.
Hongwei LiangState Key Laboratory of Pharmaceutical Biotechnology, Department of Gastroenterology, Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 210093 Nanjing, China.
Fangfang JinState Key Laboratory of Pharmaceutical Biotechnology, Department of Gastroenterology, Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 210093 Nanjing, China.
Xin YanDepartment of Respiratory Medicine, Drum Tower Hospital Affiliated to Medical School of Nanjing University, 210008 Nanjing, China.
Guifang XuDepartment of Gastroenterology, Drum Tower Hospital, Medical School of Nanjing University, 210008 Nanjing, China.
Huanhuan HuState Key Laboratory of Pharmaceutical Biotechnology, Department of Gastroenterology, Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 210093 Nanjing, China.
Gaoli LiangState Key Laboratory of Pharmaceutical Biotechnology, Department of Gastroenterology, Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 210093 Nanjing, China.
Shoubin ZhanState Key Laboratory of Pharmaceutical Biotechnology, Department of Gastroenterology, Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 210093 Nanjing, China.
Xiuting HuState Key Laboratory of Pharmaceutical Biotechnology, Department of Gastroenterology, Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 210093 Nanjing, China.
Quan ZhaoState Key Laboratory of Pharmaceutical Biotechnology, Department of Gastroenterology, Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 210093 Nanjing, China.
Yuan LiuCenter for Inflammation, Immunity and Infectious Diseases, Georgia State University, Atlanta, GA 30032.
Zhen-You JiangDepartment of Microbiology and Immunology, Basic Medicine College, Jinan University, 510632 Guangzhou, China.
Chen-Yu ZhangState Key Laboratory of Pharmaceutical Biotechnology, Department of Gastroenterology, Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 210093 Nanjing, China; cyzhang@nju.edu.cn xichen@nju.edu.cn kzen@nju.edu.cn.
Xi ChenState Key Laboratory of Pharmaceutical Biotechnology, Department of Gastroenterology, Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 210093 Nanjing, China; cyzhang@nju.edu.cn xichen@nju.edu.cn kzen@nju.edu.cn.
Ke ZenState Key Laboratory of Pharmaceutical Biotechnology, Department of Gastroenterology, Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, 210093 Nanjing, China; cyzhang@nju.edu.cn xichen@nju.edu.cn kzen@nju.edu.cn.
Nanjing Drum Tower Hospital · CNGeorgia State University · USJinan University · CNNanjing Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatic injury is often accompanied by pulmonary inflammation and tissue damage, but the underlying mechanism is not fully elucidated. Here we identify hepatic miR-122 as a mediator of pulmonary inflammation induced by various liver injuries. Analyses of acute and chronic liver injury mouse models confirm that liver dysfunction can cause pulmonary inflammation and tissue damage. Injured livers release large amounts of miR-122 in an exosome-independent manner into the circulation compared with normal livers. Circulating miR-122 is then preferentially transported to mouse lungs and taken up by alveolar macrophages, in which it binds Toll-like receptor 7 (TLR7) and activates inflammatory responses. Depleting miR-122 in mouse liver or plasma largely abolishes liver injury-induced pulmonary inflammation and tissue damage. Furthermore, alveolar macrophage activation by miR-122 is blocked by mutating the TLR7-binding GU-rich sequence on miR-122 or knocking out macrophage TLR7. Our findings reveal a causative role of hepatic miR-122 in liver injury-induced pulmonary dysfunction.

Indexed as

Signal TransductionAnimalsChemical and Drug Induced Liver InjuryDisease Models, AnimalMacrophages, AlveolarMembrane GlycoproteinsMiceMice, Inbred C57BLMice, KnockoutMice, SCIDMicroRNAsPneumoniaToll-Like Receptor 7Membrane GlycoproteinsMicroRNAsMirn122 microRNA, mouseTlr7 protein, mouseToll-Like Receptor 7circulating miR-122liver injurymacrophagepulmonary inflammatoryTLR7/8

Identifiers

PMID30867286
PMCPMC6442592
OpenAlexW2921215726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.